Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

DiaMedica Therapeutics Inc. (DMAC)

NASDAQ

$6.59

$+0.02

(+0.23%)

Pre-Market

DiaMedica Therapeutics Inc. (DMAC) Live Price Chart

Last updated: ⁦2026-09-16 11:41:00⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

DiaMedica Therapeutics Inc. (DMAC) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $6.59, with a market capitalisation of $353.21M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $5.25 to $10.42. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$353.21M
Open	$6.58
Day's High	$10.88
Day's Low	$1.12
Previous Close	$6.53
Volume	--
Average Volume	189.31K
P/E Ratio	--
52-Week High	$10.42
52-Week Low	$5.25
Dividend Yield	--
Earnings Date	--

DiaMedica Therapeutics Inc. (DMAC) Pre-Market Stock Price

DiaMedica Therapeutics Inc. (DMAC) is trading at $6.59 in pre-market trading as of 2026-09-16 11:07:00, up 0.98% ($0.06) from the previous close of $6.53

Pre-market trading shows how investors are pricing DMAC before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

DiaMedica Therapeutics Inc. (DMAC) 7-Day Stock Price Change

Over the past seven days, DiaMedica Therapeutics Inc. (DMAC) moved from $6.75 to $6.59, representing a decline of 2.31% ($0.16).

The stock traded between $6.30 and $6.97 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.

The average daily volume was 155.04 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

DMAC 52-Week Price Position

Position in Range: 26.1%

52W Low$5.25

52W High$10.42

DMAC is currently trading at $6.59, placing it 26.1% of the way from its 52-week low of $5.25 to its 52-week high of $10.42. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is DiaMedica Therapeutics Inc. (DMAC)?

DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing treatment for ischemic diseases with two main clinical programs focused on acute ischemic stroke (AIS) and preeclampsia (PE). Its main product candidate DM199 (rinvecalinase alfa) is a recombinant form of human tissue kallikrein-1, which is a synthetic version of the naturally occurring protease enzyme kallikrein-1 and a rhKLK1 undergoing clinical development studies in both AIS and PE. The other product candidate in the company's pipeline is DM300, its patented recombinant human ulinastatin, a broad-spectrum serine protease inhibitor, being developed as a potential therapy for severe acute pancreatitis.

DiaMedica Therapeutics Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	35
Exchange	NASDAQ
Company Website	https://www.diamedica.com

How to Buy DiaMedica Therapeutics Inc. (DMAC) Stock on MEXC

Eligible investors can buy real shares of DiaMedica Therapeutics Inc. (DMAC) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for DMAC and Place Your Order

Open the RealStocks trading page and search for DMAC. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is DiaMedica Therapeutics Inc. (DMAC) stock price today?

DiaMedica Therapeutics Inc. (DMAC) is currently trading at $ 6.59, up 0.98% ($0.06) from the previous close of $ 6.53. Intraday prices update in real time during regular trading hours.

2.Is DMAC stock going up or down today?

As of 2026-09-16 11:07:00, DMAC is trading at $ 6.59, up 0.98% ($0.06) from its previous close of $ 6.53. The stock has traded between $ 1.12 and $ 10.88 during today’s regular session. Past price movements do not guarantee future results.

3.What is DMAC pre-market price?

As of 2026-09-16 11:07:00, DMAC is trading at $ 6.59 in pre-market trading, up 0.98% ($0.06) from the previous close of $ 6.53. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is DMAC after-hours price?

As of 2026-09-16 11:07:00, DMAC is trading at $ 6.57 in after-hours trading, up 0.61% ($0.04) from the regular-session close of $ 6.53. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is DMAC stock trading now?

DMAC trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does DMAC sit relative to its 52-week high and low?

Over the past 52 weeks, DMAC has traded between a low of $ 5.25 and a high of $ 10.42. At $ 6.59, the stock is positioned 26.1% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is DiaMedica Therapeutics Inc. in?

DiaMedica Therapeutics Inc. (DMAC) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is DiaMedica Therapeutics Inc.'s market capitalisation and where is it listed?

DiaMedica Therapeutics Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 353.21M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is DMAC valued in terms of P/E ratio and EPS?

DMAC trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.70. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does DiaMedica Therapeutics Inc. pay a dividend?

DiaMedica Therapeutics Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.